Soligenix, Inc.

MUN:DOA0 Stock Report

Market Cap: €8.0m

Soligenix Management

Management criteria checks 3/4

Soligenix's CEO is Christopher Schaber, appointed in Aug 2006, has a tenure of 18.17 years. total yearly compensation is $700.49K, comprised of 74.2% salary and 25.8% bonuses, including company stock and options. directly owns 0.017% of the company’s shares, worth €1.36K. The average tenure of the management team and the board of directors is 10.3 years and 15.3 years respectively.

Key information

Christopher Schaber

Chief executive officer

US$700.5k

Total compensation

CEO salary percentage74.2%
CEO tenure18.2yrs
CEO ownership0.02%
Management average tenure10.3yrs
Board average tenure15.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Christopher Schaber's remuneration changed compared to Soligenix's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$700kUS$519k

-US$6m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$10m

Dec 31 2022US$711kUS$499k

-US$14m

Sep 30 2022n/an/a

-US$15m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$687kUS$485k

-US$13m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$944kUS$475k

-US$18m

Sep 30 2020n/an/a

-US$15m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$15m

Dec 31 2019US$688kUS$466k

-US$9m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

-US$8m

Dec 31 2018US$619kUS$453k

-US$9m

Sep 30 2018n/an/a

-US$8m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$8m

Dec 31 2017US$674kUS$444k

-US$7m

Compensation vs Market: Christopher's total compensation ($USD700.49K) is above average for companies of similar size in the German market ($USD501.82K).

Compensation vs Earnings: Christopher's compensation has been consistent with company performance over the past year.

CEO

Christopher Schaber (58 yo)

18.2yrs

Tenure

US$700,485

Compensation

Dr. Christopher J. Schaber, Ph D., has been the President and Chief Executive Officer at Soligenix, Inc. since August 30, 2006. Dr. Schaber has broad experience in the pharmaceutical and biotechnology indu...

Leadership Team

NamePositionTenureCompensationOwnership
Christopher Schaber
Chairman of the Board of Directors18.2yrsUS$700.49k0.017%
$ 1.3k
Jonathan Guarino
Senior VP5.1yrsUS$354.69k0.0020%
$ 162.4
Oreola Donini
Senior VP & Chief Scientific Officer9.8yrsUS$387.59k0%
$ 0
Richard Straube
Senior VP & Chief Medical Officer10.8yrsUS$249.94k0.0015%
$ 119.8

10.3yrs

Average Tenure

55yo

Average Age

Experienced Management: DOA0's management team is seasoned and experienced (10.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christopher Schaber
Chairman of the Board of Directors18.2yrsUS$700.49k0.017%
$ 1.3k
Jerome Zeldis
Independent Director13.3yrsUS$72.50k0.0042%
$ 338.5
Gregory Lapointe
Independent Director15.6yrsUS$77.50k0.0014%
$ 109.4
Robert Rubin
Independent Director15yrsUS$80.00k0.00083%
$ 66.7
Dorothy Mary Keefe
Member of Oral Mucositis Medical Advisory Boardno datano datano data
Jeffrey Hyams
Member of Pediatric Crohn's Disease Medical Advisory Boardno datano datano data
James Markowitz
Member of Pediatric Crohn's Disease Medical Advisory Boardno datano datano data
Joel Rosh
Member of Pediatric Crohn's Disease Medical Advisory Boardno datano datano data
Alain Rook
Member of Cutaneous T-Cell Lymphoma Medical Advisory Boardno datano datano data
Mark Schubert
Member of Oral Mucositis Medical Advisory Boardno datano datano data
Youn Kim
Member of Cutaneous T-Cell Lymphoma Medical Advisory Boardno datano datano data
Gary Wood
Member of Cutaneous T-Cell Lymphoma Medical Advisory Boardno datano datano data

15.3yrs

Average Tenure

69.5yo

Average Age

Experienced Board: DOA0's board of directors are seasoned and experienced ( 15.3 years average tenure).